Dergiler / Turkish Journal of Medical Sciences / 2022 / Cilt: 52 - Sayı: 2

Endocarditis-TR: Diagnosis, treatment, and prognosis of the infective endocarditis patients admitting tertiary centres of Turkey

Sayfa
445–455
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The results of this study will provide a better insight to physicians in respect to their adherence to clinical practice guidelines.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Infective endocarditis (IE) is still a significant cause of morbidity and mortality among cardiovascular diseases.
📊
Temel Bulgular & Veri:In addition to the demographic, clinical, microbiological, and echocardiographic findings of the patients, adverse events, indications for surgery, and in-hospital mortality were recorded during a 2-year time interval.
💡
Sonuç & Katkı:The results of this study will provide a better insight to physicians in respect to their adherence to clinical practice guidelines.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Infective endocarditis (IE) is still a significant cause of morbidity and mortality among cardiovascular diseases. ENDOCARDITIS-TR study aims to evaluate the compliance of the diagnostic and therapeutic methods being used in Turkey with current guidelines. Materials and methods: The ENDOCARDITIS-TR trial is a multicentre, prospective, observational study consisting of patients admitted to tertiary centres with a definite diagnose of IE. In addition to the demographic, clinical, microbiological, and echocardiographic findings of the patients, adverse events, indications for surgery, and in-hospital mortality were recorded during a 2-year time interval. Results: A total of 208 IE patients from 7 tertiary centres in Turkey were enrolled in the study. The study population included 125 (60.1%) native valve IE (NVE), 65 (31.3%) prosthetic IE (PVIE), and 18 (8.7%) intracardiac device-related IE (CDRIE). One hundred thirty-five patients (64.9%) were culture positive, and the most frequent pathogenic agent was methicillin-susceptible Staphylococcus aureus (MSSA) (18.3%). Among 155 (74.5%) patients with an indication for surgery, only 87 (56.1%) patients underwent surgery. The all-cause mortality rate was 29.3% in-hospital follow-up. Multivariable Cox regression analysis revealed that absence of surgery when indicated (HR: 3.29 95% CI: 0.93–11.64 p = 0.05), albumin level at admission (HR: 0.46 95% CI: 0.29–0.73 P < 0.01), abscess formation (HR: 2.11 95% CI: 1.01–4.38 p = 0.04) and systemic embolism (HR: 1.78 95% CI: 1.05–3.02 p = 0.03) were ascertained independent predictors of in-hospital all-cause mortality. Conclusion: The short-term results of the ENDOCARDITIS-TR trial showed the high frequency of staphylococcal IE, relatively high in-hospital mortality rates, shortage of surgical treatment despite guideline-based surgical indications and low usage of novel imaging techniques. The results of this study will provide a better insight to physicians in respect to their adherence to clinical practice guidelines.

🔖

Bu Makaleye Atıf Yap

KARATAŞ, M. B., ÇALIK, A. N., ÇANGA, Y., KOZAN, Ö., ZOGHİ, M., AKDENİZ, A., ÖZLÜK, Ö. A., AKYÜZ, Ş., EREN, S., AYHAN, G., PALİCE, A., CANDEMİR, A. (2022). Endocarditis-TR: Diagnosis, treatment, and prognosis of the infective endocarditis patients admitting tertiary centres of Turkey. Turkish Journal of Medical Sciences, Cilt: 52 - Sayı: 2, 445–455. https://ajindex.com/articles/609226

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Archives of Internal Medicine 2009
  2. 169 (5): 463-473. doi: 10.1001/archinternmed.2008.603 2. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP et al. ESC Scientific Document Group. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). European Heart Journal 2015
  3. 36 (44): 3075–3128. doi: 10.1093/eurheartj/ehv319 3. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S et al. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council
  4. Council on Cardiovascular Surgery and Anesthesia
  5. Council on Cardiovascular Radiology and Intervention
  6. Council on Cardiovascular Nursing
  7. and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009
  8. doi: 10.1161/STROKEAHA.108.192218 4. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JB et al. An updated definition of stroke for the 21 century: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2013
  9. doi: 10.1161/STR.0b013e318296aeca 5. Cetinkaya Y, Akova M, Akalın HE, Aşcıoğlu S, Hayran M et al. A retrospective review of 228 episodes of infective endocarditis where rheumatic valvular disease is still common. International Journal of Antimicrobial Agents 2001
  10. 1–7. doi:10.1016/ s0924-8579(01)00344-2 6. Leblebicioğlu H, Yilmaz H, Tasova Y, Alp E, Saba R et al. Characteristics and analysis of risk factors for mortality in infective endocarditis. European Journal of Epidemiology 2006
  11. 25–31. doi: 10.1007/s10654-005-4724-2 7. Elbey MA, Akdağ A, Kalkan MA, Kaya MG, Sayın MR et al. A multicenter study on experience of 13 tertiary hospitals in Turkey in patients with infective endocarditis. Anatolian Journal of Cardiology 2013
  12. 523–527. doi: 10.5152/akd.2013.172 8. Habib G, Erba PA, Iung B, Donal E, Cosy